Mazen Animal Health, a company spun out of Cal Poly, has closed an $11.2 million funding round, including a small investment from Cal Poly Ventures. Mazen, now based in Iowa, is developing edible biological vaccines and therapeutics for animals. The Series A, which closed in June, was led by Fall Line Capital, and included $50,000…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
